Physician profile
Rabail Sadiq
NPI 1285155994
$999.47
in general payments reported to CMS, 2019-2025
17 companies · $878 in 2025
The $878 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $121 · 2025: $878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $138.59 | 2024-2025 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $113.63 | 2025 | |
| Novo Nordisk INC | $108.24 | 2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $103.01 | 2025 | Korlym |
| Amgen INC. | $87.05 | 2025 | Tepezza, Repatha, Evenity |
| Sanofi-Aventis U.S. LLC | $77.42 | 2025 | |
| Abbvie INC. | $57.87 | 2025 | |
| Lilly USA, LLC | $53.19 | 2025 | Mounjaro, Zepbound |
| Beta Bionics, INC. | $43.94 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Dexcom, INC. | $43.16 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.20 | 2025 | Jardiance |
| Radius Health, INC. | $26.16 | 2025 | |
| Almatica Pharma LLC | $24.74 | 2025 | Teriparatide |
| Madrigal Pharmaceuticals | $24.49 | 2025 | Rezdiffra |
| Xeris Pharmaceuticals, INC. | $23.73 | 2025 | Gvoke Hypopen |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequel Med Tech, LLC | $17.77 | 2025 | Twiist |
| Insulet Corporation | $15.28 | 2025 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabail Sadiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.